<VariationArchive RecordType="classified" VariationID="9487" VariationName="NM_005502.4(ABCA1):c.1824del (p.Thr609fs)" VariationType="Deletion" Accession="VCV000009487" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-05-21" MostRecentSubmission="2018-05-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24526" VariationID="9487">
      <GeneList>
        <Gene Symbol="ABCA1" FullName="ATP binding cassette subfamily A member 1" GeneID="19" HGNC_ID="HGNC:29" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="104781006" stop="104928155" display_start="104781006" display_stop="104928155" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="107543282" stop="107690526" display_start="107543282" display_stop="107690526" Strand="-" />
          </Location>
          <OMIM>600046</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005502.4(ABCA1):c.1824del (p.Thr609fs)</Name>
      <CanonicalSPDI>NC_000009.12:104830992:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="104830993" stop="104830993" display_start="104830993" display_stop="104830993" variantLength="1" positionVCF="104830992" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="107593274" stop="107593274" display_start="107593274" display_stop="107593274" variantLength="1" positionVCF="107593273" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>T609fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_542" sequenceAccession="LRG_542">
            <Expression>LRG_542:g.102163del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_542t1" sequenceAccession="LRG_542t1">
            <Expression>LRG_542t1:c.1824del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_542p1" sequenceAccession="LRG_542p1" change="p.Thr609fs">
            <Expression>LRG_542p1:p.Thr609fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.107593274del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.107593274del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.104830993del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.104830993del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007981.1" sequenceAccession="NG_007981" sequenceVersion="1" change="g.102163del">
            <Expression>NG_007981.1:g.102163del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005502.4" sequenceAccession="NM_005502" sequenceVersion="4" change="c.1824del" MANESelect="true">
            <Expression>NM_005502.4:c.1824del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005493.2" sequenceAccession="NP_005493" sequenceVersion="2" change="p.Thr609fs">
            <Expression>NP_005493.2:p.Thr609fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA120481" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600046.0005" DB="OMIM" />
        <XRef Type="Allelic variant" ID="600046.0009" DB="OMIM" />
        <XRef Type="rs" ID="387906413" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005502.4(ABCA1):c.1824del (p.Thr609fs) AND Tangier disease" Accession="RCV000010095" Version="8">
        <ClassifiedConditionList TraitSetID="2602">
          <ClassifiedCondition DB="MedGen" ID="C0039292">Tangier disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1999-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-21" MostRecentSubmission="2018-05-21">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10431237</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2602" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6024" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Tangier disease</ElementValue>
                <XRef ID="Tangier+disease/6997" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008783" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">High density lipoprotein deficiency, type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">High density lipoprotein deficiency, Tangier type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Analphalipo-proteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha high density lipoprotein deficiency disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">A-alphalipoprotein neuropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cholesterol thesaurismosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial high density lipoprotein deficiency disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Hypoalphalipo-proteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hdl lipoprotein deficiency disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HDLDT1</ElementValue>
                <XRef Type="MIM" ID="205400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">TGD</ElementValue>
                <XRef Type="MIM" ID="205400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Tangier disease is characterized by severe deficiency or absence of high-density lipoprotein (HDL) in the circulation resulting in tissue accumulation of cholesteryl esters throughout the body, particularly in the reticuloendothelial system. The major clinical signs of Tangier disease include hyperplastic yellow-orange tonsils, hepatosplenomegaly, and peripheral neuropathy, which may be either relapsing-remitting or chronic progressive in nature. Rarer complications may include corneal opacities that typically do not affect vision, premature atherosclerotic coronary artery disease occurring in the sixth and seventh decades of life (not usually before age 40 years), and mild hematologic manifestations, such as mild thrombocytopenia, reticulocytosis, stomatocytosis, or hemolytic anemia. The clinical expression of Tangier disease is variable, with some affected individuals only showing biochemical perturbations.</Attribute>
                <XRef ID="NBK549920" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7731" />
                <XRef ID="7731" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31751110</ID>
                <ID Source="BookShelf">NBK549920</ID>
              </Citation>
              <XRef ID="31150" DB="Orphanet" />
              <XRef ID="C0039292" DB="MedGen" />
              <XRef ID="MONDO:0008783" DB="MONDO" />
              <XRef Type="MIM" ID="205400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30316" SubmissionDate="2018-02-15" DateLastUpdated="2018-05-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600046.0005_TANGIER DISEASE" title="ABCA1, 1-BP DEL, 1764G_TANGIER DISEASE" />
        <ClinVarAccession Accession="SCV000030316" DateUpdated="2018-05-21" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000056725" DateChanged="2014-08-31" Version="1" />
        </ReplacedList>
        <Classification DateLastEvaluated="1999-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 1 of 5 families with Tangier disease (TGD; 205400), Bodzioch et al. (1999) found homozygosity for a 1-bp deletion in the ABCA1 gene, removing guanine at nucleotide 1764. This mutation, localized in codon 548, created a frameshift that led to a premature translation stop 26 amino acids downstream of the deletion site. The translation product was predicted to be nonfunctional because it lacked 75% of the amino acid sequence, including all transmembrane regions and both ATP-binding cassettes. Heterozygotes in the family showed decreased HDL cholesterol levels. In this family and 1 other of the 5 reported by Bodzioch et al. (1999), premature coronary artery disease was the major clinical manifestation. In the other 3 families, splenomegaly and hyperplasia of other lymphoid tissues were prominent features.</Attribute>
              <Citation>
                <ID Source="PubMed">10431237</ID>
              </Citation>
              <XRef DB="OMIM" ID="205400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCA1" />
          </GeneList>
          <Name>ABCA1, 1-BP DEL, 1764G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1764G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600046.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TANGIER DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30316" TraitType="Disease" MappingType="Name" MappingValue="TANGIER DISEASE" MappingRef="Preferred">
        <MedGen CUI="C0039292" Name="Tangier disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

